The Food and Drug Administration continues to recommend that health care professionals inspect all current and future intravenous saline solution bags to ensure they are not simulated products made by Wallcur LLC for training purposes. On Dec. 30, FDA alerted health care professionals not to use Wallcur simulated IV products in human or animal patients after learning that some of the products had been distributed to medical clinics, surgical centers and urgent care facilities and administered to patients. Wallcur recalled the products last month and is working with FDA to revise its labeling and marketing practices to prevent a recurrence, the agency said. According to FDA, more than 40 patients received infusions of the simulated products, some of whom experienced adverse events such as fever, chills, tremors and headache. Health care professionals should report any suspected adverse events following use of the products to FDA’s MedWatch program.